• Cannabis company Valens GroWorks (TSXV:VLNS) will begin production and bottling of hand sanitiser liquid at its facility in Kelowna
  • The company will start with an initial 1,300 litre batch, to lessen product supply shortages during the COVID-19 pandemic
  • Valens has announced that it will donate 40,000 bottles of hand sanitiser to Canadian healthcare workers confronting the pandemic 
  • The company will also provide 10,000 units to public-facing workers in Shoppers Drug Mart pharmacies
  • Valens GroWorks (VLNS) is up 1.30 per cent, and is currently trading for $2.34 per share

Cannabis company, Valens GroWorks (TSXV:VLNS) is now producing and bottling hand sanitiser at its facility in Kelowna.

The company will start with an initial 1,300 litre batch, to help ease product supply shortages caused by COVID-19. 

As a cannabinoid product developer and manufacturer, Valens already has extraction and production operations. With a few tweaks, these may be applicable to hand sanitiser production. 

The company is not the first non-pharmaceutical business to reconfigure its operations for hand sanitiser production. Since the crisis started, many enterprises, including gin distilleries, have recently adapted to meet new needs. 

Valens has also announced that it will donate 40,000 bottles of hand sanitiser to Canadian healthcare workers on the front lines. The company will primarily focus on distributing to healthcare workers in British Columbia, Alberta, and Ontario.

Valens will also provide 10,000 sanitiser units to Shopper Drug Mart pharmacies, where their public-facing workers face increased infection risks.

The company is working with hospital networks, various essential services, and associations which service the vulnerable. As such, it will ensure that it can distribute supplies to those who need it most, like homeless people.

In addition to sanitiser, Valens has also donated personal protective equipment, such as gloves, gowns, and sanitising wipes.

The significant quantity of protective equipment came from the company’s existing supply. Valens is expecting a second shipment of gear, including masks, which it will donate to our defenders in healthcare. 

Valens CEO, Tyler Robson, said that the company recognises the urgency in assisting communities during the pandemic’s critical phase.

“We consider it our corporate responsibility to leverage our existing extraction and production capabilities to distribute products that have the potential to fight the transmission of this virus. 

“We are quickly mobilising our teams and resources to alleviate essential supply shortages and contribute as much as we can to those selflessly helping on the front lines,” he said. 

Valens GroWorks (VLNS) is up 1.30 per cent, and trading for $2.34 per share, at 9:35am EST.

More From The Market Online
Canopy Growth - CEO, David Klein.

Canopy Growth shareholders approve Canopy USA asset strategy

After rearranging its capital structure, Canopy Growth (TSX:WEED) will be closer to establishing a U.S.-based multi-state operator.

The Market Online’s Weekly Cannabis Report – April 12, 2024

Canada’s cannabis stock market fluctuated this week thanks to a combination of industry-specific developments and broader market trends

Avicanna completes topical gel study

Avicanna (TSX:AVCN) has completed its observational real-world evidence study of its RHO Phyto branded cannabigerol gel.

The Market Online’s Weekly Cannabis Report – April 5, 2024

Tilray Brands reveals its 420-themed 2024 product lineup, and launches will be complemented by educational 420 cannabis events across Canada.